跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
盐酸缬更昔洛韦片 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Valganciclovir Hydrochloride Tablets
Approved
化学药品
Valganciclovir Hydrochloride Tablets
AUROBINDO PHARMA LIMITED
🇨🇳 National Medical Products Administration
Approval Date
Oct 24, 2023
Approval ID
8VIYD7AlU4j
Company
AUROBINDO PHARMA LIMITED
Type
化学药品
Approval Details
Approval Id
8VIYD7AlU4j
Approval Number
国药准字HJ20230121
Generic Name
盐酸缬更昔洛韦片
Generic Name En
Valganciclovir Hydrochloride Tablets
Drug Type
化学药品
Dosage Form
片剂
Strength
0.45g(按C₁₄H₂₂N₆O₅计)
Reg Date
2023-10-24
Expired Date
2028-10-23
Company Name
AUROBINDO PHARMA LIMITED
Production Company Name
AUROBINDO PHARMA LIMITED
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Oct 24, 2023
Approval ID
8VIYD7AlU4j
Type
化学药品
Back to NMPA Approvals